Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00543010
First received: October 5, 2007
Last updated: June 11, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2003
  Primary Completion Date: November 2003 (Final data collection date for primary outcome measure)